ClotProtect Therapeutics

Private

LeedsHealthcare & Life Scienceshttps://www.clotprotect.com/

Last Round

Seed

Feb 18, 2026

Total Funding Raised

$1.62M

Company Overview

ClotProtect Therapeutics is a biotechnology company that develops small molecule anti-fibrinolytic agents for the treatment of acute hemorrhage and traumatic bleeding.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverythrombosisanticoagulantblood clot treatmentpreclinical researchsmall-molecule drugbiotech startuppharma R&Dtherapeutic candidateantithromboticdrug pipelinebiotech spin-out

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ClotProtect Therapeutics Comps

Public and private peers based on sector, stage, and business model.

ClotProtect Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ClotProtect Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Feb 18, 2026
Pre Seed	Apr 22, 2024

View all Funding Rounds

ClotProtect Therapeutics Investors

Notable investors and investment history

ClotProtect Therapeutics investors
Investor	Rounds
University of Leeds	Pre Seed
Lifted Ventures	Seed
o2h ventures	Pre Seed
Innovate UK	Seed

View all Investors

ClotProtect Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ClotProtect Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ClotProtect Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLeeds

Year Founded2024

Last FundingFeb 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.